Abstract

Objective: To report a case of large remnant ablation in a patient with metastatic papillary thyroid carcinoma. Methods: We present the initial presentation, radiologic findings and subsequent surgical and medical management. The pertinent literature and management options are also reviewed. Results: A previously healthy 80 year old woman presented to clinic with a large right-sided neck mass of several years duration. Fine needle aspiration biopsy was consistent with papillary thyroid carcinoma. Pre-operative CT imaging noted a 6cm by 6cm mass, extending into the mediastinum with mediastinal lymphadenopathy and numerous bilateral pulmonary nodules. She underwent tumor resection, however the left thyroid was left in place because the tumor extended retrosternally, and no plane could be established between the tumor and the larynx. She received 31.9 mCi of I-131 for ablation of the remaining left thyroid lobe four months later. Repeat CT imaging four months after the initial dose of I-131 showed regression of the mediastinal lymphadenopathy and pulmonary nodules, with the exception of one nodule in the right lower lobe. Approximately nine months after receiving the initial dose of I-131, she received 158.5 mCi I-131 for remnant ablation. CT imaging six months following I-131 remnant ablation noted interval increase in size of the nodule in the right lower lobe of her lung, but was otherwise unchanged from her previous CT. Conclusion: This case illustrates the use of radioactive iodine for ablation of a large thyroid remnant when total thyroidectomy is not an option in the management of metastatic papillary thyroid carcinoma.

Highlights

  • Surgery remains the mainstay for treatment of differentiated thyroid carcinoma

  • Total or near-total thyroidectomy followed by radioiodine (I-131) ablation of residual thyroid tissue is the recommended treatment for high-risk disease, including those patients with macroscopic tumor invasion and distant metastases [1]

  • Fine needle aspiration biopsy was consistent with papillary thyroid carcinoma

Read more

Summary

Introduction

Surgery remains the mainstay for treatment of differentiated thyroid carcinoma. Total or near-total thyroidectomy followed by radioiodine (I-131) ablation of residual thyroid tissue is the recommended treatment for high-risk disease, including those patients with macroscopic tumor invasion and distant metastases [1]. Total or near-total thyroidectomy is not always possible, especially in patients with extensive or locally invasive tumor. There is little evidence regarding the use of I-131 to ablate the remaining thyroid lobe in locally invasive disease.

Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.